AI Assistant
Blog
Pricing
Log In
Sign Up
The challenge of Inotuzumab ozogamicin treatment as “bridge to transplant” in relapsed/refractory B cell-acute lymphoblastic leukemia
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
